Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level

por Smit, Johan W, Duin, Erik, Steen, Herman, Oosting, Roelof, Roggeveld, Jan, Meijer, Dirk K F
Publicado em 1998

Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation

por van Marion, Denise MS, Hu, Xu, Zhang, Deli, Hoogstra-Berends, Femke, Seerden, Jean-Paul G, Loen, Lizette, Heeres, Andre, Steen, Herman, Henning, Robert H, Brundel, Bianca JJM
Publicado no Drug Des Devel Ther (2019)

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

por Lanters, Eva A. H., van Marion, Denise M. S., Kik, Charles, Steen, Herman, Bogers, Ad J. J. C., Allessie, Maurits A., Brundel, Bianca J. J. M., de Groot, Natasja M. S.
Publicado no J Transl Med (2015)